Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sinclair Pharma PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Sinclair Pharma PLC (SPH-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Aug 2016 Thomson Reuters Stock Report 11 $25.00

Sinclair Pharma Plc (SPH) - Financial and Strategic SWOT Analysis Review

Sinclair Pharma Plc (SPH) - Financial and Strategic SWOT Analysis Review Summary Sinclair Pharma plc (Sinclair), formerly Sin...

24 Aug 2016 GlobalData 95 $300.00

Wright Investors Service Comprehensive Report for Sinclair Pharma PLC

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

30 Jul 2016 Wright Reports 60 $75.00

Peel Hunt: Sinclair Pharma (Buy) - H1 trading statement delivers to drive outperformance

Peel Hunt: Sinclair Pharma (Buy) - H1 trading statement delivers to drive outperformance

19 Jul 2016 Peel Hunt 4 $12.00

Peel Hunt: Sinclair Pharma (Buy) - Changing the face of aesthetic dermatology

Changing the face of aesthetic dermatology Post the conclusion of its strategic review, Sinclair is now a pure-play aestheti...

25 May 2016 Peel Hunt 34 $357.00

Peel Hunt: Sinclair Pharma (U/R) - New transformative deal to drive (Insta) lift-off

Peel Hunt: Sinclair Pharma (U/R) - New transformative deal to drive (Insta) lift-off amy.walker@peelhunt.com

20 May 2016 Peel Hunt 4 $23.00

Thomson Reuters Stock Report - Sinclair Pharma PLC (SPH-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Sinclair Pharma PLC: Upgraded to Average

26 Apr 2016 Sadif Analytics Prime 3 $10.00

Sinclair Pharma PLC: Downgraded to Risky

25 Feb 2016 Sadif Analytics Prime 3 $10.00